Table 1.
Patient demographics
|
Characteristic |
Overall |
|
|---|---|---|
| n | % | |
|
Number |
24 |
|
|
Age |
|
|
| Range |
35-70 |
|
| Median |
60 |
|
|
Sex |
|
|
| Male |
17 |
71% |
| Female |
7 |
39% |
|
Stage |
|
|
| II |
4 |
16.5% |
| III |
16 |
67% |
| IV |
4 |
16.5% |
|
Karnofsky performance status | ||
| 90% |
7 |
29% |
| 100% |
16 |
67% |
| Unknown |
1 |
4% |
|
Prior therapy |
|
|
| None |
17 |
71% |
| Temozolomide alone |
1 |
4.1% |
| Radiation alone |
2 |
8.3% |
| RSA ablation |
1 |
4.1% |
| Interferon |
1 |
4.1% |
| Temozolomide + |
1 |
4.1% |
| Radiation | ||
| Temozolomide + |
1 | 4.1% |
| Isolated limb infusion | ||